Enwei Pharmaceutical Co., Ltd. (301331)
Market Closed
11 Aug, 06:57
XSHE XSHE Primary ¥
21. 92
+0.31
+1.4345%
¥
2.84B Market Cap
29.77 P/E Ratio
0.72% Div Yield
1.87M Volume
0 Eps
¥ 21.61
Previous Close Want to track 301331 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
301331 closed today higher at ¥21.92, an increase of 1.4345% from yesterday's close, completing a monthly increase of 0.5966% or ¥0.13. Over the past 12 months, 301331 stock lost -17.0326%.
301331 is not paying dividends to its shareholders.
Enwei Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on May 23, 2024.
The company's stock is traded on one exchange.
Enwei Pharmaceutical Co., Ltd. (301331) FAQ
What is the stock price today?
The current price is ¥21.92.
On which exchange is it traded?
Enwei Pharmaceutical Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 301331.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.72%.
What is its market cap?
As of today, the market cap is 2.84B.
Has Enwei Pharmaceutical Co., Ltd. ever had a stock split?
Enwei Pharmaceutical Co., Ltd. had 1 splits and the recent split was on May 23, 2024.
Enwei Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Yongjiang Xue CEO | XSHE Exchange | CNE100005LC7 ISIN |
| CN Country | 1,548 Employees | 28 May 2026 Last Dividend | 23 May 2024 Last Split | - IPO Date |
Overview
Enwei Pharmaceutical Co., Ltd., established in 2005, specializes in the development and sale of Chinese medicines within the domestic market of China. The company is headquartered in Chengdu, which is known as a hub for traditional Chinese medicine. By focusing on integrating traditional Chinese medical practices with modern pharmaceutical technologies, Enwei Pharmaceutical Co., Ltd. aims to cater to various health needs of its customers. It operates across several key areas in traditional medicine, including gynecology, pediatrics, and respiratory treatments, among others.
Products and Services
- Gynecology: Enwei Pharmaceutical develops medicines specifically designed for women's health issues, utilizing traditional Chinese formulas to address conditions such as menstrual discomfort, hormonal imbalances, and fertility-related concerns. These products blend ancient wisdom with modern research to provide effective solutions for gynecological health.
- Pediatrics: The company offers a range of pediatric medicines aimed at addressing common health issues in children, from digestive problems to respiratory conditions. These products are formulated with child-friendly methods, ensuring safety and efficacy for the younger population. Enwei's pediatric line is focused on harnessing gentle and natural ingredients to support children's health.
- Respiratory System: With a focus on respiratory health, Enwei Pharmaceutical provides treatments for various respiratory conditions such as asthma, chronic bronchitis, and allergic rhinitis. These medicines incorporate herbal compounds known for their efficacy in improving lung health and boosting the body's respiratory functions.
- Other Pharmaceutical Fields: Beyond these specializations, Enwei Pharmaceutical extends its product range to cover other therapeutic areas. This includes the development of general wellness products and treatments for common ailments, leveraging the broad spectrum of traditional Chinese medicine principles and ingredients to cater to the wider health needs of the populace.
Contact Information
Address: No. 458, Shuanghua Road, Chengdu, China, 610200
Phone: 86 28 8154 8888
Website: https://www.enwei.com.cn
